| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
35 Addressing the unmet social needs of gynecologic oncology patients as identified by a universal screening tool in a safety net hospital
|
Cotangco, Katherine
|
|
|
44 |
S2 |
p. S18
|
artikel
|
| 2 |
48 An urban pilot project to increase cervical cancer screening: are we helping the people who need it?
|
Villanueva, Mariana
|
|
|
44 |
S2 |
p. S24
|
artikel
|
| 3 |
51 Association of endometrial thickness with premenopausal endometroid endometrial cancer and atypical hyperplasia and correlation to patient and disease characteristics
|
Grubman, Jessica
|
|
|
44 |
S2 |
p. S25
|
artikel
|
| 4 |
AUTHOR INDEX
|
|
|
|
44 |
S2 |
p. S27-S28
|
artikel
|
| 5 |
49 Bariatric surgery and weight loss counseling among women with obesity and endometrial cancer
|
Scott, Blaire
|
|
|
44 |
S2 |
p. S24
|
artikel
|
| 6 |
9 Caged rucaparib: cancer directed delivery of PARPi
|
Marjon, Nicole
|
|
|
44 |
S2 |
p. S4-S5
|
artikel
|
| 7 |
20 Characterization of the mutational landscape of high-grade serous ovarian cancer pre- and post-neoadjuvant chemotherapy
|
Valentine, Mark C.
|
|
|
44 |
S2 |
p. S9
|
artikel
|
| 8 |
22 Clinical outcomes of patients with ovarian seromucinous tumors: a case series of 63 patients
|
Huang, Dandi
|
|
|
44 |
S2 |
p. S10
|
artikel
|
| 9 |
41 Clinical trial availability vs distribution of disease among gynecological cancers at a National Cancer Institute Comprehensive Cancer Center (NCI-CCC)
|
Nanez, Andrea I.
|
|
|
44 |
S2 |
p. S20-S21
|
artikel
|
| 10 |
25 Comparison of three testing strategies for germline genetic testing for homologous recombination deficiency mutations in women with epithelial ovarian cancer
|
Wilson, Elise M.
|
|
|
44 |
S2 |
p. S12
|
artikel
|
| 11 |
45 Disparities in carcinosarcoma: public vs private hospital system
|
Aroche-Gutierrez, Larissa
|
|
|
44 |
S2 |
p. S22-S23
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
44 |
S2 |
p. ii
|
artikel
|
| 13 |
27 Entinostat restores responsiveness to olaparib in ID8 TP53 null and ID8 TP53 null/BRCA2 null mouse ovarian cancer cell lines
|
Woodard, Tyler J.
|
|
|
44 |
S2 |
p. S13
|
artikel
|
| 14 |
28 Factors impacting genomic testing rates among epithelial ovarian cancer patients across a large community-based healthcare system
|
Kretzer, Nicole M.
|
|
|
44 |
S2 |
p. S13
|
artikel
|
| 15 |
1 Four different postoperative analgesic approaches in patients converted from laparoscopic to open gynecologic tumor surgery – trends and progress
|
Joo, Hyundeok
|
|
|
44 |
S2 |
p. S1
|
artikel
|
| 16 |
53 Frequency of homologous recombination deficiency in a large community-based cohort of epithelial ovarian cancer cases
|
Kretzer, Nicole M.
|
|
|
44 |
S2 |
p. S25-S26
|
artikel
|
| 17 |
44 Germline and somatic genetic testing trends among women with epithelial ovarian cancer
|
Wilson, Elise M.
|
|
|
44 |
S2 |
p. S22
|
artikel
|
| 18 |
8 Hybrid intracavitary and interstitial brachytherapy for cervical cancer in the outpatient setting
|
Smith, Gabriella L.
|
|
|
44 |
S2 |
p. S4
|
artikel
|
| 19 |
7 Hysterectomies for endometrial hyperplasia decreased during the first year of the COVID-19 pandemic: where have all the patients gone?
|
Coakley, Katherine
|
|
|
44 |
S2 |
p. S4
|
artikel
|
| 20 |
23 Identifying HPV vaccination initiation hot and cold spots and associated disparities in Texas
|
Nguy, Lindsey K.
|
|
|
44 |
S2 |
p. S11
|
artikel
|
| 21 |
16 Identifying the unmet social needs of gynecologic oncology patients in the safety net: comparing a self-administered screening tool to a cancer care navigation social work evaluation
|
Cotangco, Katherine
|
|
|
44 |
S2 |
p. S7-S8
|
artikel
|
| 22 |
43 Implementation of a standard same day discharge protocol for minimally invasive hysterectomies in the division of gynecologic oncology: a quality improvement project
|
Katz, Mikaela S.
|
|
|
44 |
S2 |
p. S21-S22
|
artikel
|
| 23 |
42 Implementation of California's fertility preservation health insurance benefit mandate
|
Fernandez, Estefania
|
|
|
44 |
S2 |
p. S21
|
artikel
|
| 24 |
46 Incidence of tumor spill during minimally invasive hysterectomy for early-stage, low-grade endometrial cancer
|
Khetan, Varun U.
|
|
|
44 |
S2 |
p. S23
|
artikel
|
| 25 |
19 Increasing patient understanding of the relationship between Human Papillomavirus and cervical dysplasia through standardized video education in an underserved patient population
|
Oesch, Sydney P.
|
|
|
44 |
S2 |
p. S8-S9
|
artikel
|
| 26 |
13 Investigation of adherence and barriers for posttreatment NCCN surveillance guidelines for cervical cancer
|
Mayer, Christopher
|
|
|
44 |
S2 |
p. S6
|
artikel
|
| 27 |
14 In vitro transformation of ovarian surface epithelium links a mutation in SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A, Member 4 to familial small carcinoma of the ovary hypercalcemic type
|
Krieg, Adam
|
|
|
44 |
S2 |
p. S6-S7
|
artikel
|
| 28 |
38 Lymphoscintigraphy to predict identification of inguinal sentinel lymph node in vulvar cancer
|
Brill, Joshua D.
|
|
|
44 |
S2 |
p. S19-S20
|
artikel
|
| 29 |
21 MLH1 promoter hypermethylation among mismatch repair deficient, high-intermediate risk, endometrial cancer patients is associated with differences in prognostic factors
|
Hom-Tedla, Marianne S.
|
|
|
44 |
S2 |
p. S9-S10
|
artikel
|
| 30 |
36 Mutational landscape of low-grade serous carcinoma of the ovary
|
Schink, Julian
|
|
|
44 |
S2 |
p. S18-S19
|
artikel
|
| 31 |
18 Obesity as a post-operative risk factor for women undergoing open radical hysterectomy
|
Werner, Bethany
|
|
|
44 |
S2 |
p. S8
|
artikel
|
| 32 |
12 Opportunities missed: cervix cancer screening failures in women >65
|
Ing, Brandon I.
|
|
|
44 |
S2 |
p. S6
|
artikel
|
| 33 |
29 Partnering for weight management: improving education for endometrial cancer patients
|
Jang, Allyson
|
|
|
44 |
S2 |
p. S14
|
artikel
|
| 34 |
52 Patient perceptions on integrative medicine resources at University of California Davis Cancer Center
|
Pomerantz, Tali
|
|
|
44 |
S2 |
p. S25
|
artikel
|
| 35 |
54 Patterns of genomic testing for epithelial ovarian cancer across a large community-based health care network – a real world experience
|
Kretzer, Nicole M.
|
|
|
44 |
S2 |
p. S26
|
artikel
|
| 36 |
2 Percutaneous interstitial brachytherapy ablation for targeting oligometastatic gynecologic cancers
|
Francoeur, Alex A.
|
|
|
44 |
S2 |
p. S1-S2
|
artikel
|
| 37 |
26 Pharmacologic inhibition of discoidin domain receptor 2 (DDR2) sensitizes homologous recombination proficient ovarian cancer models to treatment with olaparib
|
Stock, Elizabeth
|
|
|
44 |
S2 |
p. S12
|
artikel
|
| 38 |
40 Pre-operative non-narcotic analgesia decreases the use of postoperative narcotics
|
Spirtos, Alexandra
|
|
|
44 |
S2 |
p. S20
|
artikel
|
| 39 |
17 Pre-operative patient characteristics predict outpatient opioid use
|
Spirtos, Alexandra
|
|
|
44 |
S2 |
p. S8
|
artikel
|
| 40 |
30 Primary vulvar Ewing sarcoma: a case report and systematic literature review
|
Cathcart, Ann M.
|
|
|
44 |
S2 |
p. S14-S15
|
artikel
|
| 41 |
6 Racial differences in the mutational landscape of serous endometrial cancer
|
Garg, Ruchi
|
|
|
44 |
S2 |
p. S3-S4
|
artikel
|
| 42 |
31 Response to chemotherapy after treatment with a poly(ADP-ribose) polymerase inhibitor for patients with epithelial ovarian cancer
|
Marjon, Nicole
|
|
|
44 |
S2 |
p. S15-S16
|
artikel
|
| 43 |
10 Risks for complications and need for repeat excisional procedures of the uterine cervix
|
Robichaux, Katherine R.
|
|
|
44 |
S2 |
p. S5
|
artikel
|
| 44 |
4 Sentinel lymph node mapping for endometrial cancer in patients with morbid obesity
|
Fennimore, Nicole J.
|
|
|
44 |
S2 |
p. S2-S3
|
artikel
|
| 45 |
34 Single patient compassionate use of an investigational targeted therapy for recurrent metastatic serous uterine carcinoma: a case report and quality improvement analysis
|
Rubin, Nicole
|
|
|
44 |
S2 |
p. S17
|
artikel
|
| 46 |
47 Socioeconomic determinants of incidence of synchronous primary female cancers in Louisiana
|
Luo, Minmin
|
|
|
44 |
S2 |
p. S23
|
artikel
|
| 47 |
5 Targeting NF1/RAS pathway mutations in high-grade serous ovarian carcinoma (HGSOC) with a novel dual-mechanism ERK 1/2 inhibitor to improve chemotherapy sensitivity
|
Rubin, Nicole
|
|
|
44 |
S2 |
p. S3
|
artikel
|
| 48 |
11 The impact of the COVID pandemic on completion of radiation therapy for cervical cancer
|
Liddell, Shelby Claire
|
|
|
44 |
S2 |
p. S5
|
artikel
|
| 49 |
24 The PARP-1-DDX21-ribosome biogenesis axis is an alternative pathway targeted by PARP inhibitors in ovarian cancer
|
Kremer, Kevin M.
|
|
|
44 |
S2 |
p. S11-S12
|
artikel
|
| 50 |
37 Therapeutic implications of mutations in high grade serous ovarian carcinoma when evaluated by race
|
Garg, Ruchi
|
|
|
44 |
S2 |
p. S19
|
artikel
|
| 51 |
50 The role of DNA methyltransferase inhibitors (DNMTi) in the treatment of patients with recurrent epithelial ovarian cancer: a systematic review and meta-analysis
|
Shafa, Anousheh
|
|
|
44 |
S2 |
p. S24
|
artikel
|
| 52 |
39 Treatment efficacy of aromatase inhibitors for leiomyosarcoma of the uterus
|
Shammas, Natalie
|
|
|
44 |
S2 |
p. S20
|
artikel
|
| 53 |
3 Trends and factors associated with cost of hospitalization in ovarian cancer cytoreductive surgery: a national perspective
|
Eakin, Cortney M.
|
|
|
44 |
S2 |
p. S2
|
artikel
|
| 54 |
32 UPGRADE: phase 1 combination trial of the NaPi2b-directed antibody drug conjugate (ADC) upifitamab rilsodotin (UpRi; XMT-1536) in patients with ovarian cancer
|
Werner, Theresa L.
|
|
|
44 |
S2 |
p. S16
|
artikel
|
| 55 |
33 UPLIFT (ENGOT-ov67/GOG-3048) a pivotal cohort of upifitamab rilsodotin (XMT-1536; UpRi), a NaPi2b-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer
|
Richardson, Debra
|
|
|
44 |
S2 |
p. S16-S17
|
artikel
|
| 56 |
15 Variation in VTE prophylaxis among gynecologic oncologists
|
Strickland, Kyleigh M.
|
|
|
44 |
S2 |
p. S7
|
artikel
|
Tijdschrift beschrijving